THE EFFECT OF INTERVENING TIME AND THERAPY ON THE HORMONE RECEPTOR STATUS OF MULTIPLE BREAST-CARCINOMA BIOPSIES

被引：0
|
作者：
MOBBS, BG
HANNA, W
机构：
[1] UNIV TORONTO,TORONTO M5S 1A8,ONTARIO,CANADA
[2] WOMENS COLL HOSP,TORONTO M5S 1A8,ONTARIO,CANADA
来源：
PROCEEDINGS OF THE AMERICAN ASSOCIATION FOR CANCER RESEARCH | 1980年 / 21卷 / MAR期
关键词：
D O I：
暂无
中图分类号：
R73 [肿瘤学];
学科分类号：
100214 ;
摘要：
引用
收藏
页码：138 / 138
页数：1
相关论文
共 50 条
  • [41] HISTOCHEMICALLY DEMONSTRABLE ENZYME-ACTIVITIES AND THEIR INDEPENDENCE OF THE HORMONE RECEPTOR CONTENT IN FEMALE BREAST-CARCINOMA
    PARTANEN, S
    SYRJANEN, K
    HISTOPATHOLOGY, 1982, 6 (06) : 771 - 777
  • [42] EFFECT OF PRESURGICAL RADIOTHERAPY ON THE STEROID-RECEPTOR CONCENTRATIONS IN PRIMARY BREAST-CARCINOMA
    JANSSENS, JP
    BONTE, J
    DROCHMANS, A
    MULIER, J
    RUTTEN, J
    WITTEVRONGEL, C
    DELOECKER, W
    EUROPEAN JOURNAL OF CANCER, 1981, 17 (06) : 659 - 664
  • [43] Proliferative activity and steroid hormone receptor status in male breast carcinoma
    de Toro, MMM
    Maffini, MV
    Kass, L
    Luque, EH
    JOURNAL OF STEROID BIOCHEMISTRY AND MOLECULAR BIOLOGY, 1998, 67 (04): : 333 - 339
  • [44] Stability of Estrogen Receptor Status in Breast Carcinoma A Comparison Between Primary and Metastatic Tumors With Regard to Disease Course and Intervening Systemic Therapy
    Gong, Yun
    Han, Eric Yulong
    Guo, Ming
    Pusztai, Lajos
    Sneige, Nour
    CANCER, 2011, 117 (04) : 705 - 713
  • [45] CYTOLOGIC PARAMETERS PREDICTING ESTROGEN-RECEPTOR STATUS IN FINE NEEDLE ASPIRATES OF BREAST-CARCINOMA
    BUR, ME
    DUCATMAN, BS
    WANG, HH
    MITTEL, M
    EICK, DM
    ACTA CYTOLOGICA, 1987, 31 (05) : 671 - 671
  • [46] The effect of neoadjuvant chemotherapy on histologic grade, hormone receptor status, and Her2/neu status in breast carcinoma
    Adams, Amy L.
    Eltoum, Isam
    Krontiras, Helen
    Wang, Wenquan
    Chhieng, David C.
    BREAST JOURNAL, 2008, 14 (02): : 141 - 146
  • [47] THE RELATIONSHIP OF HISTOLOGICAL TYPE TO SURVIVAL AND ESTROGEN-RECEPTOR STATUS IN PRIMARY OPERABLE BREAST-CARCINOMA
    BROUGHTON, N
    ELLIS, IO
    ELSTON, CW
    BLAMEY, RW
    JOURNAL OF PATHOLOGY, 1987, 152 (03): : A219 - A219
  • [48] Evaluating disparities in receptor status, overall survival, and time to hormone therapy among women with breast cancer
    Taparra, Kekoa A.
    DeVille, Nicole V.
    Melendez-Ramos, Alex
    Blanco-Portillo, Javier
    Ioannidis, Alexander
    Patel, Manali I.
    Pollom, Erqi L.
    Horst, Kathleen C.
    JOURNAL OF CLINICAL ONCOLOGY, 2024, 42 (16)
  • [49] EXPRESSION OF PROLACTIN AND ITS RECEPTOR IN HUMAN BREAST-CARCINOMA
    REYNOLDS, C
    MONTONE, KT
    POWELL, CM
    TOMASZEWSKI, JE
    CLEVENGER, CV
    LABORATORY INVESTIGATION, 1995, 72 (01) : A24 - A24
  • [50] IMMUNOCYTOCHEMICAL LOCALIZATION OF PROGESTERONE-RECEPTOR IN BREAST-CARCINOMA
    PRESS, MF
    KING, WJ
    GREENE, GL
    LABORATORY INVESTIGATION, 1986, 54 (01) : A51 - A51
12345